-
1
-
-
57349156874
-
Recommendations for the diagnosis and management of Prader-Willi syndrome
-
speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS
-
Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M; speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS 2008 Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab 93:4183-4197
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 4183-4197
-
-
Goldstone, A.P.1
Holland, A.J.2
Hauffa, B.P.3
Hokken-Koelega, A.C.4
Tauber, M.5
-
2
-
-
0030016685
-
Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome
-
Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M 1996 Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab 9:393-400
-
(1996)
J Pediatr Endocrinol Metab
, vol.9
, pp. 393-400
-
-
Angulo, M.1
Castro-Magana, M.2
Mazur, B.3
Canas, J.A.4
Vitollo, P.M.5
Sarrantonio, M.6
-
4
-
-
0035719948
-
Endocrine dysfunction in Prader-Willi syndrome: A review with special reference to GH
-
Burman P, Ritzén EM, Lindgren AC 2001 Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev 22:787-799
-
(2001)
Endocr Rev
, vol.22
, pp. 787-799
-
-
Burman, P.1
Ritzén, E.M.2
Lindgren, A.C.3
-
5
-
-
77954800788
-
Endocrine disorders in children with Prader-Willi syndrome - Data from 142 children of the French database
-
Diene G, Mimoun E, Feigerlova E, Caula S, Molinas C, Grandjean H, Tauber M 2010 Endocrine disorders in children with Prader-Willi syndrome - data from 142 children of the French database. Horm Res Paediatr 74:121-128
-
(2010)
Horm Res Paediatr
, vol.74
, pp. 121-128
-
-
Diene, G.1
Mimoun, E.2
Feigerlova, E.3
Caula, S.4
Molinas, C.5
Grandjean, H.6
Tauber, M.7
-
6
-
-
0034523408
-
Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: Effect of GH therapy in 14 children
-
Tauber M, Barbeau C, Jouret B, Pienkowski C, Malzac P, Moncla A, Rochiccioli P 2000 Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children. Horm Res 53:279-287
-
(2000)
Horm Res
, vol.53
, pp. 279-287
-
-
Tauber, M.1
Barbeau, C.2
Jouret, B.3
Pienkowski, C.4
Malzac, P.5
Moncla, A.6
Rochiccioli, P.7
-
8
-
-
47949102974
-
Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: Experience from KIGS (Pfizer International Growth Database)
-
Lindgren AC, Lindberg A 2008 Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database). Horm Res 70:182-187
-
(2008)
Horm Res
, vol.70
, pp. 182-187
-
-
Lindgren, A.C.1
Lindberg, A.2
-
9
-
-
33847343358
-
Two years of growth hormone therapy in young children with Prader-Willi syndrome: Physical and neurodevelopmental benefits
-
Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB 2007 Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A 143:443-448
-
(2007)
Am J Med Genet A
, vol.143
, pp. 443-448
-
-
Myers, S.E.1
Whitman, B.Y.2
Carrel, A.L.3
Moerchen, V.4
Bekx, M.T.5
Allen, D.B.6
-
10
-
-
41849138910
-
Effects of growth hormone treatment in children presenting with Prader-Willi syndrome: The KIGS experience
-
Ranke MB, Price DA, Reiter EO, eds. Basel: Krager
-
Tauber M 2007 Effects of growth hormone treatment in children presenting with Prader-Willi syndrome: the KIGS experience. In: Ranke MB, Price DA, Reiter EO, eds. Growth hormone therapy in paediatrics - 20 years of KIGS. Basel: Krager; 377-388
-
(2007)
Growth Hormone Therapy in Paediatrics - 20 Years of KIGS
, pp. 377-388
-
-
Tauber, M.1
-
11
-
-
0028958031
-
Insulin-like growth factors and their binding proteins: Biological actions
-
Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
-
(1995)
Endocr Rev
, vol.16
, pp. 3-34
-
-
Jones, J.I.1
Clemmons, D.R.2
-
12
-
-
1942436958
-
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis
-
Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M 2004 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-1353
-
(2004)
Lancet
, vol.363
, pp. 1346-1353
-
-
Renehan, A.G.1
Zwahlen, M.2
Minder, C.3
O'Dwyer, S.T.4
Shalet, S.M.5
Egger, M.6
-
13
-
-
64249111139
-
Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis
-
Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM 2009 Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer 124:2416-2429
-
(2009)
Int J Cancer
, vol.124
, pp. 2416-2429
-
-
Rowlands, M.A.1
Gunnell, D.2
Harris, R.3
Vatten, L.J.4
Holly, J.M.5
Martin, R.M.6
-
14
-
-
2342525088
-
Cancer risk following growth hormone use in childhood: Implications for current practice
-
Ogilvy-Stuart AL, Gleeson H 2004 Cancer risk following growth hormone use in childhood: implications for current practice. Drug Saf 27:369-382
-
(2004)
Drug Saf
, vol.27
, pp. 369-382
-
-
Ogilvy-Stuart, A.L.1
Gleeson, H.2
-
15
-
-
49649094042
-
Randomized controlled GH trial: Effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome
-
Oxf
-
Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC 2008 Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome. Clin Endocrinol (Oxf) 69:443-451
-
(2008)
Clin Endocrinol
, vol.69
, pp. 443-451
-
-
Festen, D.A.1
De Lind Van Wijngaarden, R.2
Van Eekelen, M.3
Otten, B.J.4
Wit, J.M.5
Duivenvoorden, H.J.6
Hokken-Koelega, A.C.7
-
16
-
-
0038030751
-
Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome
-
Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH 2003 Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab 88:2206-2212
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 2206-2212
-
-
Haqq, A.M.1
Stadler, D.D.2
Jackson, R.H.3
Rosenfeld, R.G.4
Purnell, J.Q.5
LaFranchi, S.H.6
-
17
-
-
34247109629
-
Prader-Willi syndrome: Metabolic aspects related to growth hormone treatment
-
Kuo JY, Ditchekenian V, Manna TD, Kuperman H, Damiani D, Setian N 2007 Prader-Willi syndrome: metabolic aspects related to growth hormone treatment. Arq Bras Endocrinol Metab 51 :92-98
-
(2007)
Arq Bras Endocrinol Metab
, vol.51
, pp. 92-98
-
-
Kuo, J.Y.1
Ditchekenian, V.2
Manna, T.D.3
Kuperman, H.4
Damiani, D.5
Setian, N.6
-
18
-
-
70349931171
-
Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome
-
de Lind van Wijngaarden RF, Siemensma EP, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Bocca G, Houdijk EC, Hoorweg-Nijman JJ, Vreuls RC, Jira PE, van Trotsenburg AS, Bakker B, Schroor EJ, Pilon JW, Wit JM, Drop SL, Hokken-Koelega AC 2009 Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome. J Clin Endocrinol Metab 94:4205-4215
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 4205-4215
-
-
De Lind Van Wijngaarden, R.F.1
Siemensma, E.P.2
Festen, D.A.3
Otten, B.J.4
Van Mil, E.G.5
Rotteveel, J.6
Odink, R.J.7
Bindels-de Heus, G.C.8
Van Leeuwen, M.9
Haring, D.A.10
Bocca, G.11
Houdijk, E.C.12
Hoorweg-Nijman, J.J.13
Vreuls, R.C.14
Jira, P.E.15
Van Trotsenburg, A.S.16
Bakker, B.17
Schroor, E.J.18
Pilon, J.W.19
Wit, J.M.20
Drop, S.L.21
Hokken-Koelega, A.C.22
more..
-
19
-
-
0014525649
-
Intrauterine growth of live-born Caucasian infants at sea level: Standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation
-
Usher R, McLean F 1969 Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 74:901-910
-
(1969)
J Pediatr
, vol.74
, pp. 901-910
-
-
Usher, R.1
McLean, F.2
-
20
-
-
0025765272
-
Body mass index variations: Centiles from birth to 87 years
-
Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A 1991 Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 45:13-21
-
(1991)
Eur J Clin Nutr
, vol.45
, pp. 13-21
-
-
Rolland-Cachera, M.F.1
Cole, T.J.2
Sempe, M.3
Tichet, J.4
Rossignol, C.5
Charraud, A.6
-
22
-
-
0014899071
-
Standards for children's height at ages 2-9 years allowing for heights of parents
-
Tanner JM, Goldstein H, Whitehouse RH 1970 Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child 45:755-762
-
(1970)
Arch Dis Child
, vol.45
, pp. 755-762
-
-
Tanner, J.M.1
Goldstein, H.2
Whitehouse, R.H.3
-
23
-
-
10744225758
-
Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: Results from a multicenter study
-
on behalf of the German KIMS Board
-
Brabant G, von zur Mühlen A, Wüster C, Ranke MB, Kratzsch J, Kiess W, Ketelslegers JM, Wilhelmsen L, Hulthén L, Saller B, Mattsson A, Wilde J, Schemer R, Kann P; on behalf of the German KIMS Board 2003 Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res 60:53-60
-
(2003)
Horm Res
, vol.60
, pp. 53-60
-
-
Brabant, G.1
Von Zur Mühlen, A.2
Wüster, C.3
Ranke, M.B.4
Kratzsch, J.5
Kiess, W.6
Ketelslegers, J.M.7
Wilhelmsen, L.8
Hulthén, L.9
Saller, B.10
Mattsson, A.11
Wilde, J.12
Schemer, R.13
Kann, P.14
-
24
-
-
0029121073
-
Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation
-
Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Müller J, Skakkebaek NE 1995 Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 80:2534-2542
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 2534-2542
-
-
Juul, A.1
Dalgaard, P.2
Blum, W.F.3
Bang, P.4
Hall, K.5
Michaelsen, K.F.6
Müller, J.7
Skakkebaek, N.E.8
-
25
-
-
33746054604
-
Growth hormone treatment and adverse events in Prader-Willi syndrome: Data from KIGS (the Pfizer International Growth Database)
-
on behalf of the KIGS International Board
-
Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Wikland KA, Ranke MB, Price DA, on behalf of the KIGS International Board 2006 Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol 65:178-185
-
(2006)
Clin Endocrinol
, vol.65
, pp. 178-185
-
-
Craig, M.E.1
Cowell, C.T.2
Larsson, P.3
Zipf, W.B.4
Reiter, E.O.5
Wikland, K.A.6
Ranke, M.B.7
Price, D.A.8
-
26
-
-
0031002526
-
Peculiar body composition in patients with Prader-Labhart-Willi syndrome
-
Brambilla P, Bosio L, Manzoni P, Pietrobelli A, Beccaria L, Chiumello G 1997 Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Am J Clin Nutr 65:1369-1374
-
(1997)
Am J Clin Nutr
, vol.65
, pp. 1369-1374
-
-
Brambilla, P.1
Bosio, L.2
Manzoni, P.3
Pietrobelli, A.4
Beccaria, L.5
Chiumello, G.6
|